MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS)
Clinical trials for MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS) explained in plain language.
Never miss a new study
Get alerted when new MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS) trials appear
Sign up with your email to follow new studies for MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a quick scan replace an MRI for liver health?
Diagnosis Recruiting nowThis study is testing a new ultrasound device designed to measure how much fat is in your liver. Researchers want to see if this simpler, more accessible scanner gives results as accurate as the current gold-standard MRI test. Participants will get both scans to compare the measu…
Matched conditions: MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS)
Sponsor: Endra Lifesciences • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC
-
Scientists hunt genetic clues to mysterious liver disease in island populations
Knowledge-focused Recruiting nowThis study aims to understand why some people develop more severe fatty liver disease by looking at a specific gene (PNPLA3) in 600 adults from French overseas territories like Guadeloupe. Researchers will collect blood samples to analyze the gene and see how it relates to the st…
Matched conditions: MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS)
Sponsor: Centre Hospitalier Universitaire de la Guadeloupe • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
Cancer survivors face hidden liver threat: new study seeks answers
Knowledge-focused Recruiting nowThis study aims to understand how common a serious fatty liver disease (MASLD) is in people who survived breast or colorectal cancer 5-10 years ago. Researchers will use newer, less painful scanning methods instead of a biopsy to check 200 participants for signs of liver damage. …
Matched conditions: MASLD/MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE / METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS)
Sponsor: University of Bern • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC